Monarch Partners Asset Management’s NeoGenomics NEO Stock Holding History

Monarch Partners Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-37,330	Closed	-$295K	–	187
2017 Q1	$295K	Buy	+37,330	New	+$304K	0.03%	166
2016 Q4	–	Sell	-233,320	Closed	-$1.92M	–	192
2016 Q3	$1.92M	Buy	+233,320	New	+$1.96M	0.18%	113

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Monarch Partners Asset Management's NEO Position: Q2 2017 in Review

Monarch Partners Asset Management sold out of NeoGenomics (NEO) in Q2 2017, closing a stake of 37,330 shares — an estimated $295K sold.

Monarch Partners Asset Management first reported a position in NEO in Q3 2016 and held it in 2 quarters. The position peaked at $1.92M in Q3 2016. 134 funds tracked by Wall St. Rank hold NEO as of Q2 2017.

Monarch Partners Asset Management reported no remaining NeoGenomics position as of Q2 2017 after selling out during the quarter.
Monarch Partners Asset Management sold 37,330 NeoGenomics shares in Q2 2017, an estimated $295K.
Monarch Partners Asset Management first reported a position in NeoGenomics in Q3 2016 and held it in 2 quarters.
Monarch Partners Asset Management's NeoGenomics position peaked at $1.92M in Q3 2016.
134 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2017.

Based on Monarch Partners Asset Management's 13F filing for Q2 2017, filed 2 Aug 2017.